NTRK1 and colorectal carcinoma: Similarly, proliferation of TPM3-TRKA-positive CRC (KM12) cells was inhibited by Pz-1 with an IC50 dose of around 1.6 nM (Fig. 3C and Supplementary information, Table S1) (Fig. 2).